286 related articles for article (PubMed ID: 22681515)
21. Co-administration with cell penetrating peptide enhances the oral bioavailability of docetaxel-loaded nanoparticles.
Bu X; Zhu T; Ma Y; Shen Q
Drug Dev Ind Pharm; 2015 May; 41(5):764-71. PubMed ID: 24669977
[TBL] [Abstract][Full Text] [Related]
22. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery.
Zhang P; Liu X; Hu W; Bai Y; Zhang L
Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746
[TBL] [Abstract][Full Text] [Related]
23. A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides.
Trapani A; Lopedota A; Franco M; Cioffi N; Ieva E; Garcia-Fuentes M; Alonso MJ
Eur J Pharm Biopharm; 2010 May; 75(1):26-32. PubMed ID: 20102738
[TBL] [Abstract][Full Text] [Related]
24. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
Sajeesh S; Sharma CP
Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
[TBL] [Abstract][Full Text] [Related]
25. Folate-Functionalized Thiomeric Nanoparticles for Enhanced Docetaxel Cytotoxicity and Improved Oral Bioavailability.
Sajjad M; Khan MI; Naveed S; Ijaz S; Qureshi OS; Raza SA; Shahnaz G; Sohail MF
AAPS PharmSciTech; 2019 Jan; 20(2):81. PubMed ID: 30645705
[TBL] [Abstract][Full Text] [Related]
26. Novel hydrophobin-coated docetaxel nanoparticles for intravenous delivery: in vitro characteristics and in vivo performance.
Fang G; Tang B; Liu Z; Gou J; Zhang Y; Xu H; Tang X
Eur J Pharm Sci; 2014 Aug; 60():1-9. PubMed ID: 24815943
[TBL] [Abstract][Full Text] [Related]
27. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.
Esmaeili F; Dinarvand R; Ghahremani MH; Ostad SN; Esmaily H; Atyabi F
Anticancer Drugs; 2010 Jan; 21(1):43-52. PubMed ID: 19809300
[TBL] [Abstract][Full Text] [Related]
28. Docetaxel/2-Hydroxypropyl β -Cyclodextrin Inclusion Complex Increases Docetaxel Solubility and Release from a Nanochannel Drug Delivery System.
Ferrati S; Nicolov E; Bansal S; Hosali S; Landis M; Grattoni A
Curr Drug Targets; 2015; 16(14):1645-9. PubMed ID: 25706254
[TBL] [Abstract][Full Text] [Related]
29. Biodegradable and biocompatible polymeric nanoparticles for enhanced solubility and safe oral delivery of docetaxel: In vivo toxicity evaluation.
Sadaquat H; Akhtar M; Nazir M; Ahmad R; Alvi Z; Akhtar N
Int J Pharm; 2021 Apr; 598():120363. PubMed ID: 33556487
[TBL] [Abstract][Full Text] [Related]
30. Sulfobutylether-β-cyclodextrin/chitosan nano- and microparticles and their physicochemical characteristics.
Fülöp Z; Saokham P; Loftsson T
Int J Pharm; 2014 Sep; 472(1-2):282-7. PubMed ID: 24971695
[TBL] [Abstract][Full Text] [Related]
31. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
Lee E; Kim H; Lee IH; Jon S
J Control Release; 2009 Dec; 140(2):79-85. PubMed ID: 19712714
[TBL] [Abstract][Full Text] [Related]
32. Cyclodextrin/poly(anhydride) nanoparticles as drug carriers for the oral delivery of atovaquone.
Calvo J; Lavandera JL; Agüeros M; Irache JM
Biomed Microdevices; 2011 Dec; 13(6):1015-25. PubMed ID: 21773725
[TBL] [Abstract][Full Text] [Related]
33. Mathematical modelling of the transport of hydroxypropyl-β-cyclodextrin inclusion complexes of ranitidine hydrochloride and furosemide loaded chitosan nanoparticles across a Caco-2 cell monolayer.
Sadighi A; Ostad SN; Rezayat SM; Foroutan M; Faramarzi MA; Dorkoosh FA
Int J Pharm; 2012 Jan; 422(1-2):479-88. PubMed ID: 22101294
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of docetaxel solubility using binary and ternary solid dispersion systems.
Lim SM; Pang ZW; Tan HY; Shaikh M; Adinarayana G; Garg S
Drug Dev Ind Pharm; 2015; 41(11):1847-55. PubMed ID: 25721984
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, characterization and antitumor evaluation of CMCS-DTX conjugates as novel delivery platform for docetaxel.
Liu F; Feng L; Zhang L; Zhang X; Zhang N
Int J Pharm; 2013 Jul; 451(1-2):41-9. PubMed ID: 23608199
[TBL] [Abstract][Full Text] [Related]
36. Combined hydroxypropyl-beta-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel.
Agüeros M; Ruiz-Gatón L; Vauthier C; Bouchemal K; Espuelas S; Ponchel G; Irache JM
Eur J Pharm Sci; 2009 Nov; 38(4):405-13. PubMed ID: 19765652
[TBL] [Abstract][Full Text] [Related]
37. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
Yuan Z; Ye Y; Gao F; Yuan H; Lan M; Lou K; Wang W
Int J Pharm; 2013 Mar; 446(1-2):191-8. PubMed ID: 23422276
[TBL] [Abstract][Full Text] [Related]
38. Development of a solid supersaturatable self-emulsifying drug delivery system of docetaxel with improved dissolution and bioavailability.
Chen Y; Chen C; Zheng J; Chen Z; Shi Q; Liu H
Biol Pharm Bull; 2011; 34(2):278-86. PubMed ID: 21415541
[TBL] [Abstract][Full Text] [Related]
39. Pegylated poly(anhydride) nanoparticles for oral delivery of docetaxel.
Ruiz-Gatón L; Espuelas S; Larrañeta E; Reviakine I; Yate LA; Irache JM
Eur J Pharm Sci; 2018 Jun; 118():165-175. PubMed ID: 29597043
[TBL] [Abstract][Full Text] [Related]
40. Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Ibrutinib Delivery: A Potential Nanoformulation of Novel Kinase Inhibitor.
Zhao L; Tang B; Tang P; Sun Q; Suo Z; Zhang M; Gan N; Yang H; Li H
J Pharm Sci; 2020 Feb; 109(2):1136-1144. PubMed ID: 31606544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
